INAVAC Vaccine Phase III (Immunobridging Study) in Healthy Population Aged 12 to 17 Years Old
Condition(s):COVID-19 Pandemic; COVID-19 VaccinesLast Updated:February 28, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):COVID-19 Pandemic; COVID-19 VaccinesLast Updated:February 28, 2024Recruiting
Condition(s):COVID-19 Pandemic; COVID-19 VaccinesLast Updated:February 22, 2024Active, not recruiting
Condition(s):COVID-19 Pandemic; COVID-19 Vaccines; COVID-19 Virus DiseaseLast Updated:February 14, 2024Recruiting
Condition(s):Atrial Septal DefectLast Updated:November 18, 2023Completed
Condition(s):COVID-19 Pandemic; COVID-19 VaccinesLast Updated:June 26, 2023Recruiting
Condition(s):COVID-19 Pandemic; COVID-19 VaccinesLast Updated:August 29, 2022Recruiting
Condition(s):ERASLast Updated:July 19, 2022Completed
Condition(s):Psoriasis VulgarisLast Updated:February 24, 2022Unknown status
Condition(s):Burnout, Psychological; AnxietyLast Updated:February 22, 2022Completed
Condition(s):COVID-19 Pandemic; Vaccine ReactionLast Updated:June 15, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.